Tag Archives: business development

The Most Linked In Man in Biotech Retires after 35 Years

Chris Y

The biotech world loses one of its preeminent titans of business development this year with the retirement of Chris Yochim. Variously dubbed “the face of AstraZeneca”, “Mr. Conference”, and other monikers as colorful as his dress shirts, Chris concludes a career spanning 35 years in the pharmaceutical industry. Trained as a pharmacologist, he contributed to the identification of several candidate compounds that are marketed drugs today, but more than anything else, Chris is known as Read More >

Events  |  1 Comment  |  Email This Post
Tags: , , , , , , , ,

GEN’s “Top 10” Session Picks for the 2014 BIO International Convention

John Sterling

The following article, reproduced in full below, was originally published at Genetic Engineering & Biotechnology News. It’s been a “hot” year for biotech! As G. Steven Burrill, CEO of Burrill & Co., noted in a recent report, life science firms raised $2.9 billion in new equity capital globally from public investors in February. This included $1.1 billion raised by 18 companies that completed initial public offerings and $1.8 billion raised by 23 companies that completed Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,

Vote in the 2014 Buzz of BIO Contest!

Buzz-of-BIO

The BIO International Convention is all about raising your profile, making connections, and moving your business forward. One of the more creative and fun ways for companies to accomplish these goals is the annual Buzz of BIO contest. This is an online voting contest for the industry to cast their pick for this year’s most creative biotech company. Prizes This year, there are two categories: Pipelines of Promise, and Technologies of Tomorrow. One company from each of Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

12th Annual BIO Investor Forum Presenting Companies Announced

San Francisco skyline

Looking to lose a few pounds? Don’t want to diet or exercise? You’re not alone: fully one-third of Americans are obese, and many companies are trying to discover the first blockbuster diet drug and make a dent in the obesity epidemic. We’ll hear from one of those companies next month at the 12th Annual BIO Investor Forum, taking place October 8-9th in San Francisco. Cambridge-based Zafgen is hoping to bring to market their first-in-class obesity Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

E&Y Study: 3 Tax Tweaks that Could Spur Job Growth

87881842

A new report from Ernst & Young illustrates the economic impact of three tax proposals intended to help small businesses spur innovative research and development. The report indicates that the three tax revisions, if enacted together, could drive up research and development investments by more than $20 billion and create an estimated 623,000 new jobs at new and small firms. The report outlines the potential impact of the three proposals, which include: The R&D partnership Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , ,